CatSci are looking forward to attending and exhibiting at BOS Basel 2023; you can find us at stand 29. Taking place on 4th – 5th July, Biotech Outsourcing Strategies Basel 2023 is the key event to bring together stakeholders in R&D outsourcing.
Attending BOS Basel will be:
- Jerome Théobald – Chief Operating Officer
- Robert Crook – Director of Chemical Sciences
- Jenny Wallis – Head of Business Development – New England
- Ali Albeckai – Business Development Executive
The CatSci team are excited to network with the industry and discuss how CatSci’s award-winning expertise can expedite your medicines development programmes. Book a meeting with us here.
Our end-to-end integrated capabilities include chemical development, crystallisation and solid state, preformulation, HPAPI development, and oligonucleotides. Our offerings, along with our decades of expertise and commitment to scientific excellence, enable you to accelerate your medicines development programmes.
Plus, our partnership with AGC Pharma Chemicals, a global CDMO, allows us to provide scalable small molecule API manufacturing, from grams to tonnes, meeting the requisite quality, timelines and budget to support projects from pre-clinical development to large scale commercial production. This partnership eases your journey through the product development lifecycle and, even more importantly, expedites the delivery of life-changing new medicines to patients worldwide.
In other exciting news, we have also just re-launched SmartPath, our innovative digital API risk assessment tool. SmartPath combines the ease of digital innovation with the exclusive and invaluable consultancy of Dr Robert Dennehy, industry expert and CatSci’s Director of Material Sciences, who has over 20 years’ experience in crystallisation and solid state in large pharma. Aiding API success, SmartPath identifies risks that can cause obstacles in later development and provides solutions before they become problems; surprises can be anticipated, time can be saved, and the chance of our customers’ small molecule success can be maximised. You can take the SmartPath here.
We are driven by our purpose to get life-saving medicines into the hands of patients in need, and we are looking forward to sharing this vision with the industry at BOS Basel 2023.
If you want to book a meeting with the CatSci team at BOS 2023, get in touch here.